Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.45 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL5187639 | 0.98 | CACNA2D1 (0.44) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL11866221 | 0.82 | ALDH1A1 (0.38) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL3441626 | 0.82 | CACNA2D1 (0.44) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL3446579 | 0.78 | CACNA2D1 (0.44) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL3444754 | 0.77 | CNR1 (0.40) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL6265418 | 0.75 | CNR1 (0.41) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL5411107 | 0.75 | CNR1 (0.41) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL6265419 | 0.75 | CNR1 (0.41) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL3391989 | 0.75 | CACNA2D1 (0.55) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 | |
| SCHEMBL7054929 | 0.74 | OPRM1 (0.63) | CACNA2D1CACNA1BCACNB1CACNA1COPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1807348-A1 | MOLECULAR SIEVE SSZ-65 | Chevron U.S.A., Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| US-7083714-B2 | Hydrocarbon conversion using molecular sieve SSZ-65 | CHEVRON U.S.A. INC. (US) | 2006-08-01 | — | — | US | disclosed |
| WO-2006039213-A1 | MOLECULAR SIEVE SSZ-65 | CHEVRON U.S.A. INC. (US) | 2006-04-13 | — | — | WO | disclosed |
| US-7011811-B2 | Molecular sieve SSZ-65 composition of matter and synthesis thereof | CHEVRON U.S.A. INC. (US) | 2006-03-14 | — | — | US | disclosed |
| US-20050040074-A1 | Hydrocarbon conversion using molecular sieve SSZ-65 | CHEVRON U.S.A. INC. | 2005-02-24 | — | — | US | disclosed |
| US-20050042159-A1 | Using molecular sieve SSZ-65 for reduction of oxides of nitrogen in a gas stream | CHEVRON U.S.A. INC. | 2005-02-24 | — | — | US | disclosed |
| US-20050042169-A1 | Molecular sieve SSZ-65 composition of matter and synthesis thereof | CHEVRON U.S.A. INC. | 2005-02-24 | — | — | US | disclosed |
| US-20040187684-A1 | Using molecular sieve SSZ-65 for reduction of oxides of nitrogen in a gas stream | CHEVRON U.S.A. INC. | 2004-09-30 | — | — | US | disclosed |
| US-20040191167-A1 | Zeolite SSZ-65 composition of matter and synthesis thereof utility | CHEVRON U.S.A. INC. | 2004-09-30 | — | — | US | disclosed |
| US-20040188324-A1 | Hydrocarbon conversion using molecular sieve SSZ-65 | CHEVRON U.S.A. INC. | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050040074-A1 | Hydrocarbon conversion using molecular sieve SSZ-65 | SRP72, SSU72, SRP68 | CACNA2D1 3141/4885CACNA1B 2640/4885CACNB1 3325/4885 |
| US-20040188324-A1 | Hydrocarbon conversion using molecular sieve SSZ-65 | SRP72, SSU72, SRP68 | CACNA2D1 3195/4885CACNA1B 2743/4885CACNB1 3318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.